Novo Nordisk Says Ozempic Drug Cuts Threat of Kidney Issues

Novo Nordisk’s blockbuster weight-loss drug cuts the chance of kidney disease-related occasions in diabetic sufferers by 24%, in response to a brand new scientific trial carried out by the corporate.